Opendata, web and dolomites

SWEET CROSSTALK SIGNED

Training interdisciplinary glycoscientists to get a molecular-level grip on glycocodes at the human mucosa–microbiota interface

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SWEET CROSSTALK project word cloud

Explore the words cloud of the SWEET CROSSTALK project. It provides you a very rough idea of what is the project "SWEET CROSSTALK" about.

expertise    mucosa    interacting    platform    chemistry    glycan    entire    industry    scientists    interactions    quality    prophylactic    glycotherapeutics    arrived    modulate    drives    transferable    glycans    synergy    expert    disease    skills    molecular    microbiome    multidisciplinary    renowned    specialized    private    covers    correlates    structural    generation    public    diagnostics    synthesis    human    equip    smart    scientific    host    market    paradigm    health    stage    whereas    academic    outstanding    international    sweet    chemical    cell    proteins    microbiota    time    dominate    excellence    biology    15    credibility    intersectoral    groups    obtaining    crosstalk    innovative    understand    job    ideally    healthcare    optimal    complementary    combination    positioned    microbiology    glycoscience    smes    biotech    network    therapies    train    ranging    biochemistry    partnership    directs    training    interdisciplinary    grip    fundamental    strategy    glycocodes    ensured    competitive    interface    leaders    reshaped   

Project "SWEET CROSSTALK" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT UTRECHT 

Organization address
address: HEIDELBERGLAAN 8
city: UTRECHT
postcode: 3584 CS
website: www.uu.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 4˙117˙674 €
 EC max contribution 4˙117˙674 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT UTRECHT NL (UTRECHT) coordinator 531˙239.00
2    QUADRAM INSTITUTE BIOSCIENCE UK (NORWICH) participant 606˙345.00
3    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 561˙611.00
4    UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II IT (NAPOLI) participant 522˙999.00
5    ICENI DIAGNOSTICS LIMITED UK (NORWICH) participant 303˙172.00
6    GLYCOM AS DK (HORSHOLM) participant 297˙522.00
7    NUTRILEADS BV NL (WAGENINGEN) participant 265˙619.00
8    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 265˙619.00
9    INBIOSE NV BE (GENT) participant 256˙320.00
10    UNIVERSITE CATHOLIQUE DE LOUVAIN BE (LOUVAIN LA NEUVE) participant 256˙320.00
11    UNIVERSITAT DE BARCELONA ES (BARCELONA) participant 250˙904.00
12    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) partner 0.00
13    UNIVERSITEIT GENT BE (GENT) partner 0.00
14    UNIVERSITY OF EAST ANGLIA UK (NORWICH) partner 0.00

Map

 Project objective

Sweet Crosstalk is a multidisciplinary European Training Network built to address the challenge of understanding, at a molecular level, how glycans are involved at the human mucosa–microbiota interface, and how this correlates with human well-being. Research into the human microbiome has reshaped the paradigm of our health and disease. In order to advance further, the time has arrived to understand it at a molecular level. Glycans dominate the microbiota-host interface and are thus ideally positioned to modulate these complex interactions. The research strategy of the Sweet Crosstalk programme focuses on optimal synergy between chemistry and biology. Smart chemistry drives the research to get a molecular-level grip on the role of these glycocodes and their interacting proteins, and advances in biology directs the research. The high quality and credibility of our consortium is ensured by a strong private-public partnership with complementary expertise ranging from chemical synthesis, biochemistry, structural biology to microbiology and cell biology. Our 7 academic groups are all renowned leaders in the glycoscience and microbiome fields, whereas the complementary 4 SMEs are specialized in glycan-based diagnostics and prophylactic therapies. This unique combination of scientific excellence and industry know-how covers the entire process from obtaining fundamental insight to the development of innovative early diagnostics and glycotherapeutics. Sweet Crosstalk also represents a unique research platform to train 15 outstanding Early Stage Researchers to be the new generation of innovative scientists with expert knowledge and skills in interdisciplinary glycoscience and human microbiome research. Our international, intersectoral and interdisciplinary training programme will equip them with the necessary scientific and transferable skills that will make them highly competitive for both top European research institutions and the healthcare/biotech job market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SWEET CROSSTALK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SWEET CROSSTALK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

HeatNMof (2020)

Heating triggered drug release from nanometric inorganic-metal organic framework composites

Read More